BIOLIFE SOLUTIONS INC (BLFS)
NASDAQ • Healthcare
Last close at August 10, 2026 at 20:00 UTC
Fundamentals Charts
About BIOLIFE SOLUTIONS INC
BioLife Solutions, Inc. (NASDAQ: BLFS) develops and sells tools used in biopreservation and handling for the healthcare field, particularly cell and gene therapy workflows. Across media, thawing devices, shipping systems, freezer equipment, and storage services, it generated $96.2 million of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
BIOLIFE SOLUTIONS INC's Technical Indicators Summary
BLFS exhibits a strong bullish structure with price well above short-, medium- and long-term moving averages and robust positive volume on OBV, while ADX signals a powerful trend. Momentum measures are largely supportive—MACD and CCI are positive—although traditional oscillators show overbought readings and the stock is trading near the upper Bollinger band. Volatility is moderate by ATR and the classic pivot sits close beneath current price, offering near-term support. Technical takeaway: Trend, moving averages, and volume favor a strong buy stance despite overbought oscillators.
| Indicator | Value |
|---|---|
RSI (14) | 74.30 |
Stochastic %K (14, 3, 3) | 95.46 |
CCI (20) | 146.65 |
WPR (14) | -4.93 |
Momentum (10) | 4.85 |
MFI | 80.49 |
MACD Level (12, 26) | 1.70 |
Bollinger Bands | $27.44 - $35.09 |
ATR (14) | $1.20 (3.45%) |
ADX (14) | 59.62 |
OBV | 10,297,233 |
Classic Pivot Point | $34.51 |
Fibonacci Pivot Point | $34.51 |
Exponential Moving Averages | $25.90 - $32.95(5 indicators) |
Simple Moving Averages | $24.57 - $32.81(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
BLFS wrapped up the last session with little net change, settling at 34.64, just -0.06% away from 34.66. BLFS faces a high forward P/E as healthcare-led growth supports its valuation, per DirectorsTalk.
Trading Volume
Below 10d avg (831.6K)
439.5K
vs S&P 500 Today
Inline with Market
+0.00%
52-Week Position
Near highs
98.3%
Updated: August 11, 2026 at 12:53 UTC